Skip to main content
Prepare for an exciting September! Each week, we'll examine the latest trends in PAT, offering fresh insights straight from recent conferences. Your perspective matters, so we encourage you to share your thoughts as well. Stay informed, stay engaged, and let's explore these cutting-edge developments together. https://bit.ly/3Xw0X7k
3.144.46.9

Resources: All

Find a resource
  1. Continuous Pharmaceutical Processing

    09 Jun 2023 | Contributor(s): Zoltan K Nagy, Arwa El Hagrasy, Jim Litster

    Covers chemical engineering principles, regulatory aspects, primary and secondary manufacturing, process analytical technology and quality-by-design

  2. Continuous plug flow crystallization of pharmaceutical compounds

    09 Jun 2023 | Contributor(s): Alvarez, Alejandro J., Myerson, Allan S.

    Contains contributions from researchers in leading pharmaceutical companies, the FDA, and academic institutions

  3. Continuous powder feeding for pharmaceutical solid dosage form manufacture: a short review

    09 Jun 2023 | Contributor(s): Blackshields, Caroline A., Crean, Abina M.

    Offers an extremely well-informed look at the most promising future approaches to continuous manufacturing of innovative pharmaceutical products

  4. Continuous processing and the applications of online tools in pharmaceutical product manufacture: developments and examples

    09 Jun 2023 | Contributor(s): Ooi, Shing Minga, Sarkar, Srimantaa, Van Varenbergh, Grietb, Schoeters, Krisb, Heng, Paul Wan Sia

    Continuous processing and production in pharmaceutical manufacturing has received increased attention in recent years mainly due to the industries’ pressing needs for more efficient, cost-effective processes and production, as well as regulatory facilitation. To achieve optimum product quality,...

  5. Continuous Processing in the Manufacture of Active Pharmaceutical Ingredients and Finished Dosage Forms: An Industry Perspective

    09 Jun 2023 | Contributor(s): Poechlauer, P, Manley, JBroxterman, R, Gregertsen, B, Ridemark, M

    Continuous manufacturing as a way of producing fine chemicals, active pharmaceutical ingredients, and finished dosage forms is gaining widespread attention. Although potential benefits over traditional batch-wise production have been discussed at many occasions and appear evident, continuous...

  6. Continuous Processing of Active Pharmaceutical Ingredients Suspensions via Dynamic Cross-Flow Filtration

    09 Jun 2023 | Contributor(s): Gursch, J, Hohl, RToschkoff, G, Dujmovic, D, Brozio, J, Krumme, M, Rasenack, N, Khinast, J

    Over the last years, continuous manufacturing has created significant interest in the pharmaceutical industry. Continuous filtration at low flow rates and high solid loadings poses, however, a significant challenge. A commercially available, continuously operating, dynamic cross-flow filtration...

  7. Continuous Production of Five Active Pharmaceutical Ingredients in Flexible Plug-and-Play Modules: A Demonstration Campaign

    09 Jun 2023 | Contributor(s): Rogers, L, Briggs, NAchermann, R, Adamo, A, Azad, M, Brancazio, D, Capellades, G, Hammersmith, G, Hart, T, Imbrogno, J, Kelly, LP, Liang, GH, Neurohr, C, Rapp, K, Russell, MG, Salz, C, Thomas, DA, Weimann, L, Jamison, TF, Myerson, AS, Jensen, KF

    Traditional pharmaceutical manufacturing is based on a complex supply chain that is vulnerable to spikes in demand and interruptions. Continuous pharmaceutical production in compact modules is a potential solution that allows for drug manufacturing when and where it is needed with significantly...

  8. Continuous manufacturing of co-crystals: challenges and prospects

    09 Jun 2023 | Contributor(s): Chavan, Rahul, Thipparaboina, Rajesh, Yadav, Balvant, Shastri, Nalini

    The last decade has witnessed extensive growth in the field of co-crystallization for mitigating the solubility and dissolutionrelated issues of poorly soluble drugs. This is largely because co-crystals can modify the physicochemical properties of drugs without any covalent modification in the...

  9. Continuous manufacturing of delta mannitol by cospray drying with PVP

    09 Jun 2023 | Contributor(s): Vanhoorne, V., Van Bockstal, P-J., Van Snick, B., Peeters, E., Monteyne, T., Gomes, P., De Beer, T., Remon, J. P., Vervaet, C.

    Mannitol is a frequently used diluent in the production of tablets due to its non-hygroscopic character and low drug interaction potential. Although the delta-polymorph of mannitol has superior tabletability in comparison to alpha- and beta-mannitol, the latter are most commonly used because...

  10. Continuous manufacturing of drug substance and small molecules: process and equipment view

    09 Jun 2023 | Contributor(s): Yazdanpanah, Nima

    The continuous manufacturing of pharmaceutical compounds and fine chemicals is in high interest for the industry due to significant technical, quality, and economical advantages. This manufacturing method has its own challenges. Beside the more efficient, safer, and greener synthesis rout, a new...

  11. Continuous Manufacturing of Drug Substances and Drug Products

    09 Jun 2023

    Guideline gives information and requirements for the production of API in pharmaceutical continuous manufactring processes.

  12. Continuous Manufacturing of High Quality Pharmaceutical Cocrystals Integrated with Process Analytical Tools for In-Line Process Control

    09 Jun 2023 | Contributor(s): Moradiya, Hiren G., Islam, Muhammad, Scoutaris, Nikolaos, Halsey, Sheelagh, Chowdhry, Babur Z., Douroumis, Dennis

    A continuous manufacturing process for pharmaceutical indomethacin saccharine cocrystals was achieved by extrusion processing with high throughput. Down-stream milling and blending of the extrudates was followed by feeding the formulated cocrystals in a capsule-filling machine. By applying a...

  13. Continuous Manufacturing of Ketoprofen Delayed Release Pellets Using Melt Extrusion Technology: Application of QbD Design Space, Inline Near Infrared, and Inline Pellet Size Analysis

    09 Jun 2023 | Contributor(s): Vo, Anh, Kutz, Gerd, He, Herman, Narala, Sagar, Bandari, Suresh, Repka, Michael A.

    Delayed-release dosage forms are mainly manufactured as batch processes and include coated tablets, pellets, or particles with gastric resistant polymers. Authors propose a novel approach using the hot-melt extrusion technique to prepare delayed release dosage forms via a continuous manufacturing...

  14. Continuous manufacturing of tablets with PROMIS-line. Introduction and case studies from continuous feeding, blending and tableting

    09 Jun 2023 | Contributor(s): Simonaho, Simo-Pekka, Ketolainena, Jarkko, Ervasti, Tuomas, Toiviaine, Maunu, Korhonen, Ossi

    Drug manufacturing technology is in the midst ofmodernization and continuousmanufacturing of drug products is especially the focus of great interest. The adoption of new manufacturing approaches requires extensive cooperation between industry, regulatory bodies, academics and equipment...

  15. Continuous Manufacturing Process Development from Lab to Market, Role of Digital Tools

    09 Jun 2023 | Contributor(s): Yazdanpanah, Nima

    The continuous manufacturing of pharmaceutical compounds and fine chemicals is in high interest for the industry due to significant technical, quality, and economical advantages. Beside the more efficient, safer, and greener synthesis route, a new process design paradigm and equipment selection...

  16. Continuous manufacturing process monitoring of pharmaceutical solid dosage form: A case study

    09 Jun 2023 | Contributor(s): Roggo, Yves, Pauli, Victoria, Jelsch, Morgane, Pellegatti, Laurent, Elbaz, Frantz, Ensslin, Simon, Kleinebudde, Peter, Krumme, Markus

    The most prevalent pharmaceutical dosage forms at present are granular solids in the form of oral tablets and capsules. While effective in releasing drug rapidly upon contact with gastrointestinal fluid, their manufacture, which relies on particulate processing, is fraught with difficulties...

  17. Continuous manufacturing technologies in upstream pharmaceutical supply chains: Combining engineering and managerial criteria

    09 Jun 2023 | Contributor(s): Aulakh, PK, Settanni, E, Srai, JS

    The COVID-19 pandemic exposed vulnerabilities in upstream pharmaceutical supply chains (PSC). One is that the global supply of active pharmaceutical ingredients (APIs) is overly dependent on few locations and large-scale batch manufacturing. Regulators hope to enable more dependable location...

  18. Continuous manufacturing of pharmaceuticals

    09 Jun 2023 | Contributor(s): Johannes Khinast, Jukka Rantanen

    A comprehensive look at existing technologies and processes for continuous manufacturing of pharmaceuticals.As rising costs outpace new drug development, the pharmaceutical industry has come under intense pressure to improve the efficiency of its manufacturing processes. Continuous process...

  19. Continuous Flow C-Glycosylation via Metal-Halogen Exchange: Process Understanding and Improvements toward Efficient Manufacturing of Remdesivir

    09 Jun 2023 | Contributor(s): von;Keutz, T, Williams, JD, Kappe, CO

    As remdesivir is the first approved treatment for COVID-19 (SARS-CoV-2), its production is likely to be of vital importance in the near future. Continuous flow processing has been demonstrated as a key technology in the manufacturing of highvolume active pharmaceutical ingredients and is...

  20. Continuous flow technology vs. the batch-by-batch approach to produce pharmaceutical compounds

    09 Jun 2023 | Contributor(s): Cole, KP, Johnson, MD

    Introduction: For the manufacture of small molecule drugs, many pharmaceutical innovator companies have recently invested in continuous processing, which can offer significant technical and economic advantages over traditional batch methodology. This Expert Review will describe the reasons for...

  21. Continuous flow upgrading of glycerol toward oxiranes and active pharmaceutical ingredients thereof

    09 Jun 2023 | Contributor(s): Morodo, R, Gerardy, RPetit, G, Monbaliu, JCM

    A robust continuous flow procedure for the transformation of bio-based glycerol into high value-added oxiranes (epichlorohydrin and glycidol) is presented. The flow procedure features a central hydrochlorination/dechlorination sequence and provides economically and environmentally favorable...

  22. Continuous granulation in the pharmaceutical industry

    09 Jun 2023 | Contributor(s): Vervaet, C, Remon, JP

    Traditionally the manufacturing of pharmaceutical dosage forms has been a batch-wise process and continuous processes have limited applications in a pharmaceutical manufacturing plant. However, several factors (reduction of cost, improved process efficiency, optimal use of equipment, flexibility...

  23. Continuous Heterogeneous Crystallization on Excipient Surfaces

    09 Jun 2023 | Contributor(s): Yazdanpanah, Nimaa, Testa, Christopher J., Perala, Siva R. K., Jensen, Keith D., Braatz, Richard D., Myerson, Allan S., Trout, Bernhardt L.

    A novel continuous heterogeneous crystallization process is, developed in which the active pharmaceutical ingredient (API) is crystallized directly on the surface of an excipient within the crystallizer. The produet is subsequently dried and formed into tablets without the need for complex...

  24. Continuous integrated filtration, washing and drying of aspirin: digital design of a novel intensified unit

    09 Jun 2023 | Contributor(s): Destro, F, Wang, VAbdi, M, Feng, X, Wood, E, Coleman, S, Firth, P, Barton, A, Barolo, M, Nagy, ZK

    Within the recent modernization of pharmaceutical manufacturing, an important milestone consists in developing enabling technologies for end-to-end continuous production of drug products. Continuous filtration, washing and drying of active pharmaceutical ingredients from mother liquors in...

  25. Continuous manufacture of polymeric cellular dosage forms

    09 Jun 2023 | Contributor(s): Blaesi, Aron H, Saka, Nannaji

    The most prevalent pharmaceutical dosage forms at present are granular solids in the form of oral tablets and capsules. While effective in releasing drug rapidly upon contact with gastrointestinal fluid, their manufacture, which relies on particulate processing, is fraught with difficulties...